Neuroendocrine neoplasms: Evolving and future treatments

Neuroendocrine neoplasms (NENs) are relatively rare neoplasms. Most NENs are slowly progressing malignancies with prolonged survival even in the presence of advanced metastatic disease, implying an increased need for additional therapies on failure of those initially administered. However, a subset of NENs may display truly aggressive behavior, often refractory to current chemotherapeutic regimens, underlining the need for more appropriate...